NYSE · IQV
IQVIA Holdings Inc.
$265.91-$9.16 (-3.33%)
IQVIA Holdings Inc.’s quoted price sits in the upper half of its reported 52-week range, 6.54% below the high.
Loading market information…
SES · P8A.SI · SGD
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 01:22 AM UTC. Cached market data; not a live quote.
One-year closing-price history · SGD. Historical prices are not a forecast.
Cordlife Group Limited’s quoted price sits in the lower half of its reported 52-week range, 65.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Cordlife Group Limited’s forward annual dividend is SGD 0.01 per share, paid annual. The forward yield is 9.89% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Cordlife Group Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Established in Singapore in 2001, Cordlife Group Limited functions as an investment holding company, delivering cord blood banking solutions across a global footprint that includes Singapore, Hong Kong, India, Malaysia, and the Philippines. Its operations are structured into two distinct divisions: Banking and Diagnostics. The Banking division is responsible for the collection, processing, storage, and analysis of vital biological samples such as cord blood, cord lining, and various tissue samples. Meanwhile, the Diagnostics division furnishes an array of diagnostic tests, encompassing genetic and metabolic screenings for newborns, pediatric vision and hearing assessments, allergen testing for children, and genetic evaluations for talent identification. Beyond these core services, Cordlife also engages in corneal lenticule banking, gut microbiome storage, and offers lifestyle-focused genetic screening for adults. The company further provides "Moms Up," a mobile application designed to supply parenting information and resources pertinent to health, wellness, and lifestyle needs. Completing its diverse portfolio, Cordlife offers medical laboratory services, marketing support, property investment, alongside specialized consulting and research and development in the medical and pharmaceutical sectors.
Latest available per-share figures in SGD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:03 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$265.91-$9.16 (-3.33%)
IQVIA Holdings Inc.’s quoted price sits in the upper half of its reported 52-week range, 6.54% below the high.
$237.13-$52.93 (-18.25%)
Illumina, Inc.’s quoted price sits in the upper half of its reported 52-week range, 23.35% below the high.
$251.96-$0.96 (-0.38%)
Quest Diagnostics Incorporated’s quoted price sits in the upper half of its reported 52-week range, 1.96% below the high.
MYR 7.85MYR 0.00 (0.0%)
IHH Healthcare Berhad’s quoted price sits in the lower half of its reported 52-week range, 18.06% below the high.
$354.09-$22.01 (-5.85%)
Charles River Laboratories International, Inc.’s quoted price sits in the upper half of its reported 52-week range, 6.73% below the high.
SGD 0.74-SGD 0.01 (-0.68%)
Riverstone Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 25.38% below the high.
₩1,924+₩4 (+0.21%)
Access Bio, Inc.’s quoted price sits in the lower half of its reported 52-week range, 59.11% below the high.
SGD 0.34SGD 0.00 (0.0%)
HC Surgical Specialists Limited’s quoted price sits in the lower half of its reported 52-week range, 15.0% below the high.
